European Medicines Agency (EMA) on March 24, 2017 announced that over 300 drug approvals should be s
Mar 27, 2017
0 min read
1 Comment
Józefa Śliwa
Sep 17
Reading about the EMA’s March 2017 announcement instantly reminded me of the day my brother was finally able to get his long‑awaited medication after years of waiting for a European approval. He had been on a clinical trial for a rare condition, and every time we checked the EMA’s updates we felt a mix of hope and anxiety. When the news broke that more than 300 drugs had cleared the regulatory hurdle, it felt like a collective sigh of relief for patients like him, whose lives hinge on timely access. I remember the phone call from his doctor, the cautious optimism in his voice, and the moment we both realized that the bureaucracy we’d been fighting against could actually work…
Reading about the EMA’s March 2017 announcement instantly reminded me of the day my brother was finally able to get his long‑awaited medication after years of waiting for a European approval. He had been on a clinical trial for a rare condition, and every time we checked the EMA’s updates we felt a mix of hope and anxiety. When the news broke that more than 300 drugs had cleared the regulatory hurdle, it felt like a collective sigh of relief for patients like him, whose lives hinge on timely access. I remember the phone call from his doctor, the cautious optimism in his voice, and the moment we both realized that the bureaucracy we’d been fighting against could actually work…